INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2005

In older adults with mild vitamin B12 deficiency, daily oral cyanocobalamin doses of 647 to 1032 mcg produced 80% to 90% of maximal methylmalonic acid reduction.

A randomized, parallel-group, double-blind, dose-finding trial evaluated the effects of 16 weeks of daily oral cyanocobalamin (2.5, 100, 250, 500, and 1000 mcg) in 120 older adults with mild vitamin B12 deficiency. Daily doses of 2.5, 100, 250, 500, and 1000 mcg were associated with mean plasma methylmalonic acid reductions of 16%, 16%, 23%, 33%, and 33%, respectively. Daily doses of 647 to 1032 mcg were associated with 80% to 90% of the estimated maximum reduction in plasma methylmalonic acid.

Study type
Randomized, parallel-group, double-blind, dose-finding trial
Who was studied
120 older people with mild vitamin B12 deficiency
What was measured
Dose producing 80% to 90% of estimated maximal reduction in plasma methylmalonic acid

THE PAPER

Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial.

Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, van Staveren WA. Arch Intern Med, 2005.

PubMed 15911731 ↗DOI 10.1001/archinte.165.10.1167 ↗

Nutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.